James M. Hindman
CIK 1617615 · EVP, Finance & Bus. Dev., CFO · last filed 2025-12-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$100.6K
Companies
5
Total Filings
21
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARAY | Director | 294,804 | $0.34 | $100.6K | $0 | 8 | 2025-12-02 |
| Urovant Sciences Ltd. (UROV) Delisted | Director | 9,000 | $16.24 | $146.2K | $0 | 2 | 2020-07-23 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | — | $15.90 | — | $0 | 4 | 2020-06-23 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Director | — | — | — | $0 | 2 | 2019-06-03 |
| ALLERGAN INC (AGN) Delisted | EVP, Finance & Bus. Dev., CFO | 29,715 | — | — | $0 | 3 | 2015-02-24 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-10-31 | ALLERGAN INC (AGN) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.